Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Christina S Kwon"'
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Patients with type 2 diabetes (T2D) typically use several drug treatments during their lifetime. There is a debate about the best second-line therapy after metformin monotherapy failure due to the increasing number of available an
Externí odkaz:
https://doaj.org/article/21eec791f3964678a5516659517a695b
Autor:
Remo Panaccione, Eric B Collins, Gil Y Melmed, Severine Vermeire, Silvio Danese, Peter D R Higgins, Christina S Kwon, Wen Zhou, Dapo Ilo, Dolly Sharma, Yuri Sanchez Gonzalez, Si-Tien Wang
Background Given rapid innovation in advanced therapies for moderately to severely active ulcerative colitis (UC), we investigated their comparative efficacy and safety during induction and maintenance through network meta-analysis. Methods Using Bay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70a63ec594c0873f9d08b56d26c75c0
https://lirias.kuleuven.be/handle/20.500.12942/718639
https://lirias.kuleuven.be/handle/20.500.12942/718639
Publikováno v:
Journal of Health Economics and Outcomes Research (2021)
Journal of Health Economics and Outcomes Research
Journal of Health Economics and Outcomes Research
Introduction: This systematic literature review analyzed published evidence on IgA nephropathy (IgAN), focusing on US epidemiology, health-related quality of life (HRQoL), and economic burden of illness. Methods: Using Preferred Reporting Items for S
Autor:
Lauren J Lee, Christina S Kwon, Carla Mamolo, Elizabeth T. Masters, Anna Forsythe, Ira Jacobs
Publikováno v:
ClinicoEconomics and Outcomes Research. 12:693-709
Purpose Non-muscle invasive bladder cancer (NMIBC) is a malignancy restricted to the inner lining of the bladder. Intravesical Bacillus Calmette-Guerin (BCG) following transurethral resection of the bladder tumor is the mainstay first-line treatment
Autor:
Anuja Roy, Menaka Bhor, John Schneider, Maria Socorro O Portella, Alejandro Allepuz, Christina S Kwon, Timothy Pham, Anna Forsythe, Qayyim Said
Publikováno v:
Journal of Comparative Effectiveness Research. 9:447-457
Aim: Eltrombopag and romiplostim are US FDA approved for treatment of immune thrombocytopenia in patients with insufficient response to other treatments. Clinical or real-world data comparing outcomes of the two drugs are limited. Methods: This retro
Publikováno v:
Journal of Clinical Oncology. 40:e20576-e20576
e20576 Background: Although SCLC is sensitive to first-line chemotherapy, most patients experience relapse, and options for 2L therapy are limited. Patients with relapsed SCLC have a poor prognosis, particularly those with resistant disease. To bette
Autor:
Andrew Briggs, Menaka Bhor, Jaclyn Hearnden, Anna Forsythe, Mike Dolph, Gabriel Tremblay, Christina S Kwon, Anuja Roy
Publikováno v:
Journal of Comparative Effectiveness Research. 7:775-784
Aim: Eltrombopag and romiplostim are comparable second-line therapies in chronic immune thrombocytopenia. Treatment decisions are made in different contexts. A framework was created to outline decision pathways for physicians and payers. Materials &
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Health Services Research
BMC Health Services Research
Background Patients with type 2 diabetes (T2D) typically use several drug treatments during their lifetime. There is a debate about the best second-line therapy after metformin monotherapy failure due to the increasing number of available antidiabeti
Publikováno v:
Value in Health. 24:S236
Autor:
Victoria M. Raymond, Junhua Yu, Mike Dolph, Christina S Kwon, Theresa Hoang, Anna Forsythe, Vicky Ho, Kathryn Lang
Publikováno v:
Gastroenterology. 160:S-603